# FDA Inspection 1025203 - Aerie Pharmaceuticals, Inc. - August 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/aerie-pharmaceuticals-inc/748c36ed-6c40-4265-9426-7fc83c00360d
Source feed: FDA_Inspections

> FDA Inspection 1025203 for Aerie Pharmaceuticals, Inc. on August 23, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1025203
- Company Name: Aerie Pharmaceuticals, Inc.
- Inspection Date: 2017-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/aerie-pharmaceuticals-inc/a5cb5b6f-9720-4180-bca9-87a367f547aa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
